The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model
Neutrophil infiltration, proinflammatory cytokines, eicosanoid generation and oxidative stress have been implicated in colitis. Resveratrol is a polyphenolic compound found in grapes and wine, with multiple pharmacological actions, including anti‐inflammatory, antioxidant, antitumour and immunomodul...
Saved in:
Published in: | British journal of pharmacology Vol. 147; no. 8; pp. 873 - 885 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
Oxford, UK
Blackwell Publishing Ltd
01-04-2006
Nature Publishing Nature Publishing Group |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Neutrophil infiltration, proinflammatory cytokines, eicosanoid generation and oxidative stress have been implicated in colitis. Resveratrol is a polyphenolic compound found in grapes and wine, with multiple pharmacological actions, including anti‐inflammatory, antioxidant, antitumour and immunomodulatory activities. In a previous report, we documented that resveratrol decreases the degree of inflammation associated with acute experimental colonic inflammation, but its effects on chronic experimental colitis remain undetermined.
The aim of this research was to investigate the effects of resveratrol on the chronic colonic injury caused by intracolonic instillation of trinitrobenzenesulphonic acid (TNBS) in rats. The inflammatory response was assessed by histology and myeloperoxidase activity. Tumour necrosis factor alpha (TNF‐α) production, histological and histochemical analysis of the lesions were also carried out. We determined the production of prostaglandin (PG) E2 and D2 in colon mucosa, as well as cyclooxygenase (COX)‐1 and ‐2 and nuclear transcription factor NF‐kappa B (NF‐κB) p65 protein expression. Finally, since resveratrol has been found to modulate apoptosis, we intended to elucidate its effects on colonic mucosa under chronic inflammatory conditions.
Resveratrol (10 mg kg−1 day−1) significantly attenuated the damage score and corrected the disturbances in morphology associated to injury. In addition, the degree of neutrophil infiltration and the levels of TNF‐α were significantly ameliorated. Resveratrol did not modify PGD2 levels but returned the decreased PGE2 values to basal levels and also reduced COX‐2 and the NF‐κB p65 protein expression. Furthermore, treatment of rats with resveratrol caused a significant increase of TNBS‐induced apoptosis in colonic cells.
In conclusion, resveratrol reduces the damage in chronic experimentally induced colitis, alleviates the oxidative events, returns PGE2 production to basal levels and stimulates apoptosis in colonic cells.
British Journal of Pharmacology (2006) 147, 873–885. doi:10.1038/sj.bjp.0706469 |
---|---|
AbstractList | Neutrophil infiltration, proinflammatory cytokines, eicosanoid generation and oxidative stress have been implicated in colitis. Resveratrol is a polyphenolic compound found in grapes and wine, with multiple pharmacological actions, including anti-inflammatory, antioxidant, antitumour and immunomodulatory activities. In a previous report, we documented that resveratrol decreases the degree of inflammation associated with acute experimental colonic inflammation, but its effects on chronic experimental colitis remain undetermined. The aim of this research was to investigate the effects of resveratrol on the chronic colonic injury caused by intracolonic instillation of trinitrobenzenesulphonic acid (TNBS) in rats. The inflammatory response was assessed by histology and myeloperoxidase activity. Tumour necrosis factor alpha (TNF-alpha) production, histological and histochemical analysis of the lesions were also carried out. We determined the production of prostaglandin (PG) E2 and D2 in colon mucosa, as well as cyclooxygenase (COX)-1 and -2 and nuclear transcription factor NF-kappa B (NF-kappaB) p65 protein expression. Finally, since resveratrol has been found to modulate apoptosis, we intended to elucidate its effects on colonic mucosa under chronic inflammatory conditions. Resveratrol (10 mg kg(-1) day(-1)) significantly attenuated the damage score and corrected the disturbances in morphology associated to injury. In addition, the degree of neutrophil infiltration and the levels of TNF-alpha were significantly ameliorated. Resveratrol did not modify PGD2 levels but returned the decreased PGE2 values to basal levels and also reduced COX-2 and the NF-kappaB p65 protein expression. Furthermore, treatment of rats with resveratrol caused a significant increase of TNBS-induced apoptosis in colonic cells. In conclusion, resveratrol reduces the damage in chronic experimentally induced colitis, alleviates the oxidative events, returns PGE2 production to basal levels and stimulates apoptosis in colonic cells. Neutrophil infiltration, proinflammatory cytokines, eicosanoid generation and oxidative stress have been implicated in colitis. Resveratrol is a polyphenolic compound found in grapes and wine, with multiple pharmacological actions, including anti‐inflammatory, antioxidant, antitumour and immunomodulatory activities. In a previous report, we documented that resveratrol decreases the degree of inflammation associated with acute experimental colonic inflammation, but its effects on chronic experimental colitis remain undetermined. The aim of this research was to investigate the effects of resveratrol on the chronic colonic injury caused by intracolonic instillation of trinitrobenzenesulphonic acid (TNBS) in rats. The inflammatory response was assessed by histology and myeloperoxidase activity. Tumour necrosis factor alpha (TNF‐ α ) production, histological and histochemical analysis of the lesions were also carried out. We determined the production of prostaglandin (PG) E 2 and D 2 in colon mucosa, as well as cyclooxygenase (COX)‐1 and ‐2 and nuclear transcription factor NF‐kappa B (NF‐ κ B) p65 protein expression. Finally, since resveratrol has been found to modulate apoptosis, we intended to elucidate its effects on colonic mucosa under chronic inflammatory conditions. Resveratrol (10 mg kg −1 day −1 ) significantly attenuated the damage score and corrected the disturbances in morphology associated to injury. In addition, the degree of neutrophil infiltration and the levels of TNF‐ α were significantly ameliorated. Resveratrol did not modify PGD 2 levels but returned the decreased PGE 2 values to basal levels and also reduced COX‐2 and the NF‐ κ B p65 protein expression. Furthermore, treatment of rats with resveratrol caused a significant increase of TNBS‐induced apoptosis in colonic cells. In conclusion, resveratrol reduces the damage in chronic experimentally induced colitis, alleviates the oxidative events, returns PGE 2 production to basal levels and stimulates apoptosis in colonic cells. British Journal of Pharmacology (2006) 147 , 873–885. doi: 10.1038/sj.bjp.0706469 Neutrophil infiltration, proinflammatory cytokines, eicosanoid generation and oxidative stress have been implicated in colitis. Resveratrol is a polyphenolic compound found in grapes and wine, with multiple pharmacological actions, including anti-inflammatory, antioxidant, antitumour and immunomodulatory activities. In a previous report, we documented that resveratrol decreases the degree of inflammation associated with acute experimental colonic inflammation, but its effects on chronic experimental colitis remain undetermined. The aim of this research was to investigate the effects of resveratrol on the chronic colonic injury caused by intracolonic instillation of trinitrobenzenesulphonic acid (TNBS) in rats. The inflammatory response was assessed by histology and myeloperoxidase activity. Tumour necrosis factor alpha (TNF- α ) production, histological and histochemical analysis of the lesions were also carried out. We determined the production of prostaglandin (PG) E 2 and D 2 in colon mucosa, as well as cyclooxygenase (COX)-1 and -2 and nuclear transcription factor NF-kappa B (NF- κ B) p65 protein expression. Finally, since resveratrol has been found to modulate apoptosis, we intended to elucidate its effects on colonic mucosa under chronic inflammatory conditions. Resveratrol (10 mg kg −1 day −1 ) significantly attenuated the damage score and corrected the disturbances in morphology associated to injury. In addition, the degree of neutrophil infiltration and the levels of TNF- α were significantly ameliorated. Resveratrol did not modify PGD 2 levels but returned the decreased PGE 2 values to basal levels and also reduced COX-2 and the NF- κ B p65 protein expression. Furthermore, treatment of rats with resveratrol caused a significant increase of TNBS-induced apoptosis in colonic cells. In conclusion, resveratrol reduces the damage in chronic experimentally induced colitis, alleviates the oxidative events, returns PGE 2 production to basal levels and stimulates apoptosis in colonic cells. Neutrophil infiltration, proinflammatory cytokines, eicosanoid generation and oxidative stress have been implicated in colitis. Resveratrol is a polyphenolic compound found in grapes and wine, with multiple pharmacological actions, including anti‐inflammatory, antioxidant, antitumour and immunomodulatory activities. In a previous report, we documented that resveratrol decreases the degree of inflammation associated with acute experimental colonic inflammation, but its effects on chronic experimental colitis remain undetermined. The aim of this research was to investigate the effects of resveratrol on the chronic colonic injury caused by intracolonic instillation of trinitrobenzenesulphonic acid (TNBS) in rats. The inflammatory response was assessed by histology and myeloperoxidase activity. Tumour necrosis factor alpha (TNF‐α) production, histological and histochemical analysis of the lesions were also carried out. We determined the production of prostaglandin (PG) E2 and D2 in colon mucosa, as well as cyclooxygenase (COX)‐1 and ‐2 and nuclear transcription factor NF‐kappa B (NF‐κB) p65 protein expression. Finally, since resveratrol has been found to modulate apoptosis, we intended to elucidate its effects on colonic mucosa under chronic inflammatory conditions. Resveratrol (10 mg kg−1 day−1) significantly attenuated the damage score and corrected the disturbances in morphology associated to injury. In addition, the degree of neutrophil infiltration and the levels of TNF‐α were significantly ameliorated. Resveratrol did not modify PGD2 levels but returned the decreased PGE2 values to basal levels and also reduced COX‐2 and the NF‐κB p65 protein expression. Furthermore, treatment of rats with resveratrol caused a significant increase of TNBS‐induced apoptosis in colonic cells. In conclusion, resveratrol reduces the damage in chronic experimentally induced colitis, alleviates the oxidative events, returns PGE2 production to basal levels and stimulates apoptosis in colonic cells. British Journal of Pharmacology (2006) 147, 873–885. doi:10.1038/sj.bjp.0706469 |
Author | Martín, Antonio Ramón Villegas, Isabel Sánchez‐Hidalgo, Marina De La Lastra, Catalina Alarcón |
AuthorAffiliation | 1 Department of Pharmacology, Faculty of Pharmacy, University of Seville, Profesor García González Street 2, Sevilla 41012, Spain |
AuthorAffiliation_xml | – name: 1 Department of Pharmacology, Faculty of Pharmacy, University of Seville, Profesor García González Street 2, Sevilla 41012, Spain |
Author_xml | – sequence: 1 givenname: Antonio Ramón surname: Martín fullname: Martín, Antonio Ramón – sequence: 2 givenname: Isabel surname: Villegas fullname: Villegas, Isabel – sequence: 3 givenname: Marina surname: Sánchez‐Hidalgo fullname: Sánchez‐Hidalgo, Marina – sequence: 4 givenname: Catalina Alarcón surname: De La Lastra fullname: De La Lastra, Catalina Alarcón |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17731715$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/16474422$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1uEzEUhS1URNPCliWykNg1wZ7xjD0bJKgKRaoEi7K2_HNNHHnsYE_S5h146Bpl1MKKlSWf795zdM8ZOokpAkKvKVlR0or3ZbPSm-2KcNKzfniGFpTxftm1gp6gBSGELykV4hSdlbIhpIq8e4FOac84Y02zQL9v14DBOTBTwcnhDGUPWU05hQus8HZ9mJIKcO8jtpD9Hix2OY2Vs_jORygXOEVs1jlFb7CPLqhxVJOvnz7analYHVURw_22zo8QJxXC4VE0KfjJFzwmC-Eleu5UKPBqfs_Rj89Xt5fXy5tvX75efrxZmq7rhqXmrGdOaN1C04C2zoiOQ08aZq222nUdH3qhG80apzgXnPd2oEy0zHZcU9Oeow_HvdudHsGaGiqrILc1n8oHmZSX_yrRr-XPtJeU9_XSvC54Oy_I6dcOyiQ3aZdjzSwbyunABREVWh0hk1MpGdyjASXyT3mybGQtT87l1YE3f8d6wue2KvBuBlQxKrisovHlieO8re5d5dojd-cDHP5jKz99v276dmgfALNcuRY |
CODEN | BJPCBM |
CitedBy_id | crossref_primary_10_1016_j_enzmictec_2010_09_004 crossref_primary_10_3390_antiox9010035 crossref_primary_10_1002_mnfr_200800148 crossref_primary_10_1021_jf071741n crossref_primary_10_1186_1476_511X_7_14 crossref_primary_10_1158_1940_6207_CAPR_09_0117 crossref_primary_10_1021_jf803638d crossref_primary_10_3390_jfb6010033 crossref_primary_10_3390_antiox9080669 crossref_primary_10_1124_jpet_109_160838 crossref_primary_10_1111_j_1476_5381_2010_00785_x crossref_primary_10_1016_j_bcp_2011_06_043 crossref_primary_10_1186_1742_2094_6_26 crossref_primary_10_1016_j_bbapap_2009_09_015 crossref_primary_10_1016_j_biopha_2019_01_001 crossref_primary_10_1017_S0007114511007227 crossref_primary_10_3748_wjg_v21_i21_6572 crossref_primary_10_3109_02652048_2011_559284 crossref_primary_10_34172_apb_2020_023 crossref_primary_10_1016_j_nlm_2010_08_009 crossref_primary_10_1016_j_taap_2020_114919 crossref_primary_10_1016_j_yexcr_2019_06_024 crossref_primary_10_1053_j_gastro_2013_07_015 crossref_primary_10_1177_0960327110383638 crossref_primary_10_1016_j_ejmech_2019_111805 crossref_primary_10_1038_bjp_2008_330 crossref_primary_10_1016_j_intimp_2006_11_006 crossref_primary_10_1080_02713683_2020_1803920 crossref_primary_10_1371_journal_pone_0109048 crossref_primary_10_1016_j_jnutbio_2012_11_009 crossref_primary_10_1007_s00204_008_0309_7 crossref_primary_10_1111_j_1753_4887_2009_00210_x crossref_primary_10_1111_bph_15895 crossref_primary_10_1248_bpb_b19_00786 crossref_primary_10_3389_fncel_2019_00030 crossref_primary_10_1007_s00417_014_2604_8 crossref_primary_10_1155_2020_4253174 crossref_primary_10_1016_j_ijpharm_2019_118713 crossref_primary_10_1177_011542650802300149 crossref_primary_10_1111_j_1476_5381_2009_00572_x crossref_primary_10_1208_s12249_010_9435_7 crossref_primary_10_1053_j_gastro_2020_05_011 crossref_primary_10_13005_bpj_2831 crossref_primary_10_1016_j_ejphar_2010_01_025 crossref_primary_10_1016_j_intimp_2016_03_004 crossref_primary_10_3109_1061186X_2010_504272 crossref_primary_10_1089_jmf_2013_2976 crossref_primary_10_1155_2012_751629 crossref_primary_10_1007_s11101_012_9265_1 crossref_primary_10_1371_journal_pone_0139147 crossref_primary_10_3389_fimmu_2022_855342 crossref_primary_10_1016_j_peptides_2008_07_013 crossref_primary_10_1016_j_taap_2013_01_009 crossref_primary_10_1016_j_ijpharm_2009_10_016 crossref_primary_10_1016_j_jep_2011_08_019 crossref_primary_10_3390_antiox9080725 crossref_primary_10_1016_j_foodhyd_2020_106291 crossref_primary_10_3390_nu11051000 crossref_primary_10_1165_rcmb_2016_0192OC crossref_primary_10_1111_j_1745_7254_2007_00694_x crossref_primary_10_3390_ijms23020920 crossref_primary_10_1016_j_phrs_2017_08_002 crossref_primary_10_1042_BST0351156 crossref_primary_10_1016_j_ejphar_2013_08_040 crossref_primary_10_1016_j_ijfoodmicro_2010_04_007 crossref_primary_10_1111_j_1745_7254_2007_00690_x crossref_primary_10_3390_ijms15022368 crossref_primary_10_1007_s00213_015_4188_3 crossref_primary_10_1002_jps_22212 crossref_primary_10_1097_MCO_0b013e3282f0cef2 crossref_primary_10_3390_molecules21010033 crossref_primary_10_1080_08941930903214701 crossref_primary_10_1002_biof_1298 crossref_primary_10_1016_j_bbadis_2014_12_024 crossref_primary_10_1016_j_tox_2007_04_012 crossref_primary_10_1016_j_jff_2015_05_046 crossref_primary_10_1016_j_pharmthera_2018_06_013 crossref_primary_10_1021_jm1007006 crossref_primary_10_3390_molecules25225453 crossref_primary_10_1189_jlb_1112557 crossref_primary_10_1016_j_ejphar_2007_01_047 crossref_primary_10_1016_j_taap_2007_03_025 crossref_primary_10_3389_fnut_2017_00059 crossref_primary_10_1007_s11101_013_9320_6 crossref_primary_10_1016_j_ejphar_2008_10_005 crossref_primary_10_1016_j_bbrc_2015_01_034 crossref_primary_10_1515_bc_2010_100 crossref_primary_10_1093_toxsci_kfq360 crossref_primary_10_1016_j_jnutbio_2015_12_002 crossref_primary_10_1016_j_nutres_2016_11_003 crossref_primary_10_1177_014556130808701010 crossref_primary_10_1016_j_cbi_2015_06_026 crossref_primary_10_1371_journal_pone_0024740 crossref_primary_10_1007_s12602_011_9081_8 crossref_primary_10_1016_j_ijpharm_2010_12_015 crossref_primary_10_1016_j_lfs_2023_121915 crossref_primary_10_1016_j_intimp_2015_04_026 crossref_primary_10_1080_10408390903584094 crossref_primary_10_1016_j_ejphar_2009_03_062 crossref_primary_10_1016_j_fct_2014_04_032 crossref_primary_10_1016_j_jnutbio_2011_06_003 crossref_primary_10_1017_S095442241700021X crossref_primary_10_1007_s11064_014_1340_0 crossref_primary_10_1152_ajpgi_00083_2011 crossref_primary_10_1007_s00394_011_0235_y crossref_primary_10_1021_acs_molpharmaceut_0c00048 crossref_primary_10_3748_wjg_v24_i25_2673 crossref_primary_10_1016_j_regpep_2006_12_029 crossref_primary_10_1016_j_phrs_2012_05_006 crossref_primary_10_1038_bjp_2008_137 crossref_primary_10_1038_mi_2014_35 crossref_primary_10_1080_1028415X_2019_1596613 crossref_primary_10_1007_s10620_011_1821_9 crossref_primary_10_1177_1753465807086096 crossref_primary_10_1016_j_etap_2014_02_006 crossref_primary_10_1155_2017_8051870 crossref_primary_10_1017_S000711451300007X crossref_primary_10_1007_s11033_020_05753_4 crossref_primary_10_1177_0884533611423927 crossref_primary_10_1016_j_tiv_2012_06_015 crossref_primary_10_1016_j_fct_2007_09_002 crossref_primary_10_1080_10408398_2019_1570913 crossref_primary_10_1016_j_intimp_2008_08_003 crossref_primary_10_1080_10584587_2021_1911228 crossref_primary_10_1016_j_tifs_2021_05_001 crossref_primary_10_1016_j_freeradbiomed_2019_09_021 crossref_primary_10_1155_2012_805762 crossref_primary_10_3390_ijms19020426 crossref_primary_10_31612_2616_4868_8_2023_11 crossref_primary_10_1016_j_ejphar_2011_08_036 crossref_primary_10_1016_j_fct_2019_02_044 crossref_primary_10_1016_j_ntt_2020_106905 crossref_primary_10_1016_j_carbpol_2014_09_012 crossref_primary_10_1016_j_jep_2010_01_024 crossref_primary_10_1111_jpn_12536 crossref_primary_10_1586_17474124_2_2_261 crossref_primary_10_3390_molecules26195891 crossref_primary_10_3390_ijms20174321 crossref_primary_10_1016_j_ejphar_2007_01_070 crossref_primary_10_1080_10284150600841547 crossref_primary_10_1002_JLB_3A1218_476RR crossref_primary_10_2174_2589977515666230502153206 crossref_primary_10_1016_j_bbi_2011_07_236 crossref_primary_10_3390_molecules191117578 crossref_primary_10_3390_metabo13010096 crossref_primary_10_1016_j_freeradbiomed_2018_07_002 crossref_primary_10_1016_j_arcmed_2015_05_005 crossref_primary_10_1007_s00394_009_0004_3 crossref_primary_10_1080_01635580903407213 crossref_primary_10_1007_s00217_020_03586_w crossref_primary_10_1080_09540100802483608 crossref_primary_10_5812_ipmn_117170 crossref_primary_10_1111_jfbc_13369 crossref_primary_10_1016_j_ejphar_2014_12_009 crossref_primary_10_3109_08830185_2011_642909 crossref_primary_10_1089_jmf_2020_4712 crossref_primary_10_1016_j_tifs_2021_02_075 crossref_primary_10_3109_10837450_2012_696268 crossref_primary_10_1016_j_fct_2008_10_029 crossref_primary_10_1111_ijcp_12993 crossref_primary_10_1039_D1BM00118C crossref_primary_10_1016_j_trsl_2012_10_008 crossref_primary_10_1016_j_jnutbio_2022_109101 crossref_primary_10_3390_antiox12101886 crossref_primary_10_1002_ibd_21843 crossref_primary_10_1007_s11101_023_09866_z crossref_primary_10_1371_journal_pone_0019881 crossref_primary_10_1038_s41598_024_52309_8 crossref_primary_10_1002_mnfr_201100374 crossref_primary_10_1016_j_gastrohep_2009_09_006 crossref_primary_10_1155_2014_139873 |
Cites_doi | 10.1016/j.intimp.2003.07.002 10.1136/gut.52.12.1714 10.1182/blood-2002-11-3550 10.1016/S0304-3835(03)00157-5 10.1016/S0016-5085(89)80016-2 10.1002/hep.510270512 10.1016/j.mrfmmm.2004.05.018 10.1016/S0027-5107(02)00330-5 10.1002/mnfr.200500022 10.1016/0016-5085(90)90280-E 10.1021/np0498410 10.1038/nature01960 10.1016/j.bcp.2003.12.024 10.2174/1568011033353443 10.1023/A:1012860509440 10.1016/S0014-2999(01)01410-8 10.1023/A:1026651408998 10.1016/S0006-2952(01)00775-4 10.1007/s00384-004-0585-5 10.1016/0076-6879(90)86172-R 10.1074/jbc.M002577200 10.1016/S0140-6736(02)11395-X 10.1007/BF01954148 10.1042/bj3180603 10.1016/S0006-2952(99)00380-9 10.1016/S0016-5085(89)80079-4 10.1016/j.ejphar.2003.09.033 10.1080/003655202320621436 10.3748/wjg.v9.i3.408 10.1007/s00011-004-1266-0 10.1055/s-2004-818940 10.1207/S15327914NC4402_12 10.1016/S0006-2952(97)00544-3 10.1111/j.1572-0241.2003.08703.x 10.1016/S0016-5085(98)70259-8 10.1053/j.gastro.2003.08.027 10.1016/S0014-2999(02)01494-2 10.1038/sj.emboj.7600244 10.1152/ajpgi.2000.279.1.G238 10.1021/jo0497860 10.1096/fj.04-3582fje 10.1152/ajpcell.00351.2003 10.1016/S0014-2999(02)02949-7 10.1038/9550 10.1016/j.clnu.2005.02.009 10.1016/j.intimp.2004.08.008 10.1097/00054725-200409000-00010 10.1016/S0008-6363(00)00102-4 10.1038/sj.bjp.0705688 10.1097/00042737-200207000-00008 |
ContentType | Journal Article |
Copyright | 2006 British Pharmacological Society 2006 INIST-CNRS Copyright Nature Publishing Group Apr 2006 Copyright 2006, Nature Publishing Group 2006 Nature Publishing Group |
Copyright_xml | – notice: 2006 British Pharmacological Society – notice: 2006 INIST-CNRS – notice: Copyright Nature Publishing Group Apr 2006 – notice: Copyright 2006, Nature Publishing Group 2006 Nature Publishing Group |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QP 7RV 7TK 7X7 7XB 88E 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P NAPCQ PQEST PQQKQ PQUKI PRINS 5PM |
DOI | 10.1038/sj.bjp.0706469 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts ProQuest Nursing & Allied Health Database Neurosciences Abstracts Health & Medical Complete (ProQuest Database) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest Central (Alumni) |
DatabaseTitleList | ProQuest Central Student CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1476-5381 |
EndPage | 885 |
ExternalDocumentID | 1041872411 10_1038_sj_bjp_0706469 16474422 17731715 BPH2639 |
Genre | article Journal Article |
GroupedDBID | --- .3N .55 .GJ 05W 0R~ 1OC 23N 24P 2WC 31~ 33P 36B 3O- 3SF 3V. 4.4 52U 52V 53G 5GY 6J9 7RV 7X7 8-0 8-1 88E 8AO 8FE 8FH 8FI 8FJ 8R4 8R5 8UM A00 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCUV ABDBF ABPVW ABQWH ABUWG ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFKRA AFPWT AFRAH AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB AOIJS ATUGU AZBYB AZVAB B0M BAFTC BAWUL BBNVY BENPR BFHJK BHBCM BHPHI BKEYQ BMXJE BPHCQ BRXPI BVXVI C45 CAG CCPQU COF CS3 DCZOG DIK DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EAS EBC EBD EBS ECV EJD EMB EMK EMOBN ENC ESX EX3 F5P FUBAC FYUFA G-S GODZA GX1 H.X HCIFZ HGLYW HMCUK HYE HZ~ J5H KBYEO LATKE LEEKS LH4 LITHE LK8 LOXES LSO LUTES LW6 LYRES M1P M7P MEWTI MK0 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N9A NAPCQ NF~ O66 O9- OIG OK1 OVD P2P P2W P4E PQQKQ PROAC PSQYO Q.N Q2X QB0 RIG ROL RPM RWI SJN SUPJJ SV3 TEORI TR2 TUS UKHRP UPT WBKPD WH7 WHWMO WIH WIJ WIK WIN WOHZO WOW WVDHM WXSBR X7M XV2 Y6R YHG ZGI ZXP ZZTAW ~8M ~S- 08R AAJUZ AAPBV AAUGY AAVGM ABCVL ABHUG ABPTK ABWRO ACXME ADAWD ADDAD AFVGU AGJLS IQODW ZA5 CGR CUY CVF ECM EIF NPM AAMNL AAYXX CITATION 7QP 7TK 7XB 8FK AZQEC DWQXO GNUQQ K9. PQEST PQUKI PRINS 5PM |
ID | FETCH-LOGICAL-c5559-b7464f8bb3e22ebdfc857e6024ddbdbf557968b2b42fa778776d914834d57b1c3 |
IEDL.DBID | RPM |
ISSN | 0007-1188 |
IngestDate | Tue Sep 17 21:07:34 EDT 2024 Thu Oct 10 16:06:09 EDT 2024 Thu Nov 21 20:55:53 EST 2024 Sat Sep 28 07:46:54 EDT 2024 Sun Oct 22 16:07:51 EDT 2023 Sat Aug 24 01:03:04 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Wine nuclear transcription factor NF-kappa B (NF-KB) apoptosis Inflammation prostaglandin (PG) Antioxidant Stilbene derivatives Chronic Phytoalexin Resveratrol Digestive diseases Intestinal disease Models Colitis cyclooxygenase (COX) trinitrobenzenesulphonic acid (TNBS) neutrophils |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5559-b7464f8bb3e22ebdfc857e6024ddbdbf557968b2b42fa778776d914834d57b1c3 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0706469 |
PMID | 16474422 |
PQID | 217197808 |
PQPubID | 42104 |
PageCount | 13 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_1760707 proquest_journals_217197808 crossref_primary_10_1038_sj_bjp_0706469 pubmed_primary_16474422 pascalfrancis_primary_17731715 wiley_primary_10_1038_sj_bjp_0706469_BPH2639 |
PublicationCentury | 2000 |
PublicationDate | April 2006 |
PublicationDateYYYYMMDD | 2006-04-01 |
PublicationDate_xml | – month: 04 year: 2006 text: April 2006 |
PublicationDecade | 2000 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Basingstoke – name: England – name: London |
PublicationTitle | British journal of pharmacology |
PublicationTitleAlternate | Br J Pharmacol |
PublicationYear | 2006 |
Publisher | Blackwell Publishing Ltd Nature Publishing Nature Publishing Group |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Nature Publishing – name: Nature Publishing Group |
References | 2002; 14 2004; 286 1990; 98 2000; 47 2004; 69 2004; 25 2004; 67 2004; 23 2003; 195 2002; 236 1999; 44 1998; 115 1983; 15 2003; 52 1990; 186 2003; 98 2001; 42 2005; 24 2001; 297 2003b; 460 2004; 70 2000; 59 2002; 44 2003; 9 2003; 481 2003; 3 2000; 60 2003; 125 1998; 55 1998; 27 2003; 523–524 2003a; 3 2000; 279 2004; 141 2002; 2 2002; 3 2000; 275 2005; 49 1999; 5 2001; 25 2001; 62 2003; 33 2004; 10 1989; 96 2004; 53 1996; 318 2005; 19 2004; 555 2003; 425 2004; 19 2005; 5 2005; 51 2003; 28 2003; 102 15837718 - FASEB J. 2005 Jul;19(9):1193-5 12169985 - Eur J Gastroenterol Hepatol. 2002 Jul;14(7):757-65 15095144 - Planta Med. 2004 Apr;70(4):305-9 10371510 - Nat Med. 1999 Jun;5(6):698-701 15589480 - Int Immunopharmacol. 2005 Jan;5(1):185-93 6192115 - Histochem J. 1983 Jun;15(6):571-82 14724828 - Gastroenterology. 2003 Dec;125(6):1750-61 11356911 - J Pharmacol Exp Ther. 2001 Jun;297(3):915-25 15896420 - Clin Nutr. 2005 Jun;24(3):339-52 10963727 - Cardiovasc Res. 2000 Aug 18;47(3):549-55 15001427 - Am J Physiol Cell Physiol. 2004 Apr;286(4):C931-9 15013856 - Biochem Pharmacol. 2004 Apr 1;67(7):1399-410 9586953 - Biochem Pharmacol. 1998 Mar 15;55(6):811-6 12817628 - Ann Clin Lab Sci. 2003 Spring;33(2):226-31 2105254 - Gastroenterology. 1990 Mar;98(3):615-25 15015312 - Zhongguo Zhong Yao Za Zhi. 2003 Mar;28(3):246-9 14636824 - Int Immunopharmacol. 2003 Dec;3(13-14):1731-41 15028639 - Br J Pharmacol. 2004 Mar;141(6):997-1005 15303463 - Trop Gastroenterol. 2004 Jan-Mar;25(1):9-14 12020690 - Eur J Pharmacol. 2002 May 3;442(1-2):125-35 15152190 - EMBO J. 2004 Jun 16;23(12):2369-80 11705464 - Biochem Pharmacol. 2001 Nov 1;62(9):1299-308 12559383 - Eur J Pharmacol. 2003 Jan 24;460(2-3):209-18 15990703 - Minerva Gastroenterol Dietol. 2005 Jun;51(2):127-45 12689943 - Blood. 2003 Aug 1;102(3):987-95 14633948 - Gut. 2003 Dec;52(12):1714-20 10718345 - Biochem Pharmacol. 2000 Apr 1;59(7):865-70 12408502 - Scand J Gastroenterol Suppl. 2002;(236):37-41 11716848 - Eur J Pharmacol. 2001 Nov 9;431(1):103-10 12939617 - Nature. 2003 Sep 11;425(6954):191-6 15832402 - Mol Nutr Food Res. 2005 May;49(5):405-30 10898767 - Am J Physiol Gastrointest Liver Physiol. 2000 Jul;279(1):G238-44 14642796 - Eur J Pharmacol. 2003 Nov 28;481(2-3):281-91 15472516 - Inflamm Bowel Dis. 2004 Sep;10(5):564-72 10630507 - Dig Dis Sci. 1999 Dec;44(12):2523-9 15568761 - J Nat Prod. 2004 Nov;67(11):1777-82 10934192 - J Biol Chem. 2000 Oct 20;275(42):32681-7 14638336 - Am J Gastroenterol. 2003 Nov;98(11):2372-82 15471458 - J Org Chem. 2004 Oct 15;69(21):7101-7 12767528 - Cancer Lett. 2003 Jun 10;195(2):193-9 2172726 - Methods Enzymol. 1990;186:729-42 12628512 - Mutat Res. 2003 Feb-Mar;523-524:145-50 9581680 - Hepatology. 1998 May;27(5):1265-74 9753490 - Gastroenterology. 1998 Oct;115(4):874-82 12424006 - Lancet. 2002 Nov 2;360(9343):1410-8 2539306 - Gastroenterology. 1989 May;96(5 Pt 1):1290-300 10910059 - Cancer Res. 2000 Jul 1;60(13):3477-83 12632486 - World J Gastroenterol. 2003 Mar;9(3):408-11 12734068 - Nutr Cancer. 2002;44(2):193-201 15083321 - Int J Colorectal Dis. 2004 Sep;19(5):451-60 12678904 - Curr Med Chem Anticancer Agents. 2003 Mar;3(2):77-93 15476850 - Mutat Res. 2004 Nov 2;555(1-2):33-51 11820457 - Inflammation. 2001 Oct;25(5):301-10 15241569 - Inflamm Res. 2004 Jul;53(7):329-36 8809053 - Biochem J. 1996 Sep 1;318 ( Pt 2):603-8 2914642 - Gastroenterology. 1989 Mar;96(3):795-803 e_1_2_6_51_1 e_1_2_6_53_1 e_1_2_6_32_1 e_1_2_6_30_1 YUE G. (e_1_2_6_55_1) 2001; 297 e_1_2_6_19_1 e_1_2_6_13_1 e_1_2_6_11_1 e_1_2_6_34_1 e_1_2_6_17_1 e_1_2_6_15_1 e_1_2_6_57_1 e_1_2_6_43_1 e_1_2_6_20_1 e_1_2_6_41_1 e_1_2_6_9_1 e_1_2_6_5_1 e_1_2_6_7_1 e_1_2_6_24_1 e_1_2_6_49_1 e_1_2_6_3_1 e_1_2_6_22_1 e_1_2_6_28_1 e_1_2_6_45_1 SCHMIDT C. (e_1_2_6_46_1) 2005; 51 e_1_2_6_26_1 e_1_2_6_47_1 KURTOVIC J. (e_1_2_6_36_1) 2004; 25 e_1_2_6_52_1 e_1_2_6_54_1 e_1_2_6_10_1 e_1_2_6_50_1 LIU L. (e_1_2_6_38_1) 2003; 28 e_1_2_6_35_1 e_1_2_6_12_1 e_1_2_6_33_1 HOLMES‐MCNARY M. (e_1_2_6_31_1) 2000; 60 e_1_2_6_18_1 e_1_2_6_39_1 e_1_2_6_56_1 e_1_2_6_16_1 e_1_2_6_37_1 e_1_2_6_42_1 BOSCOLO P. (e_1_2_6_14_1) 2003; 33 e_1_2_6_21_1 e_1_2_6_40_1 e_1_2_6_8_1 e_1_2_6_4_1 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_48_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_29_1 e_1_2_6_44_1 e_1_2_6_27_1 |
References_xml | – volume: 10 start-page: 564 year: 2004 end-page: 572 article-title: Catalposide, a compound isolated from catalpa ovata, attenuates induction of intestinal epithelial proinflammatory gene expression and reduces the severity of trinitrobenzene sulfonic acid‐induced colitis in mice publication-title: Inflamm. Bowel Dis. – volume: 44 start-page: 193 year: 2002 end-page: 201 article-title: Resveratrol induces downregulation in survivin expression and apoptosis in HTLV‐1‐infected cell lines: a prospective agent for adult T cell leukemia chemotherapy publication-title: Nutr. Cancer – volume: 44 start-page: 2523 year: 1999 end-page: 2529 article-title: Experimental colitis induced by trinitrobenzenesulphonic acid. An ultrastructural and histochemical study publication-title: Digest. Dis. Sci. – volume: 62 start-page: 1299 year: 2001 end-page: 1308 article-title: Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell‐mediated cytotoxicity, and cytokine production publication-title: Biochem. Pharmacol. – volume: 141 start-page: 997 year: 2004 end-page: 1005 article-title: Neuroprotective effects of resveratrol against beta‐amyloid‐induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C publication-title: Br. J. Pharmacol. – volume: 3 start-page: 125 year: 2002 end-page: 135 article-title: Chronic gastric ulcer healing in rats subjected to selective and non‐selective cyclooxygenase‐2 inhibitors publication-title: Eur. J. Pharmacol. – volume: 5 start-page: 698 year: 1999 end-page: 701 article-title: Inducible cyclooxygenase may have anti‐inflammatory properties publication-title: Nat. Med. – volume: 3 start-page: 1731 year: 2003a end-page: 1741 article-title: A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium‐induced colitis in mice publication-title: Int. Immunopharmacol. – volume: 24 start-page: 339 year: 2005 end-page: 352 article-title: Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut‐associated lymphoid tissue immune response publication-title: Clin. Nutr. – volume: 52 start-page: 1714 year: 2003 end-page: 1720 article-title: Cyclooxygenase 2 mediates post‐inflammatory colonic secretory and barrier dysfunction publication-title: Gut – volume: 15 start-page: 571 year: 1983 end-page: 582 article-title: Mucosal mast cells of the rat intestine: a re‐evaluation of fixation and staining properties, with special reference to protein blocking and solubility of the granular glycosaminoglycan publication-title: Histochem J. – volume: 55 start-page: 811 year: 1998 end-page: 816 article-title: Interaction of transresveratrol with plasma lipoproteins publication-title: Biochem. Pharmacol. – volume: 98 start-page: 615 year: 1990 end-page: 625 article-title: Misoprostol provides a colonic mucosal protective effect during acetic acid‐induced colitis in rats publication-title: Gastroenterology – volume: 195 start-page: 193 year: 2003 end-page: 199 article-title: Enhanced MTT‐reducing activity under growth inhibition by resveratrol in CEM‐C7H2 lymphocytic leukemia cells publication-title: Cancer Lett. – volume: 67 start-page: 1777 year: 2004 end-page: 1782 article-title: Mechanism‐based inactivation of COX‐1 by red wine ‐hydroquinones: a structure–activity relationship study publication-title: J. Nat. Prod. – volume: 25 start-page: 9 year: 2004 end-page: 14 article-title: Recent advances in biological therapy for inflammatory bowel disease publication-title: Trop. Gastroenterol. – volume: 51 start-page: 127 year: 2005 end-page: 145 article-title: Etiology and pathogenesis of inflammatory bowel disease publication-title: Minerva Gastroenterol. Dietol. – volume: 318 start-page: 603 year: 1996 end-page: 608 article-title: Changes associate with aging and replicative senescence in the regulation of transcription factor nuclear factor‐ B publication-title: Biochem. J. – volume: 14 start-page: 757 year: 2002 end-page: 765 article-title: Role of mucins in inflammatory bowel disease: important lessons from experimental models publication-title: Eur. J. Gastroenterol. Hepatol. – volume: 60 start-page: 3477 year: 2000 end-page: 3483 article-title: Chemopreventive properties of ‐resveratrol are associated with inhibition of activation of the IkappaB kinase publication-title: Cancer Res. – volume: 19 start-page: 1193 year: 2005 end-page: 1195 article-title: Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease publication-title: FASEB J. – volume: 460 start-page: 209 year: 2003b end-page: 218 article-title: Effects of dosmalfate, a new cytoprotective agent, on acute and chronic trinitrobenzene sulphonic acid‐induced colitis in rats publication-title: Eur. J. Pharmacol. – volume: 5 start-page: 185 year: 2005 end-page: 193 article-title: Resveratrol inhibits nitric oxide and TNF‐alpha production by lipopolysaccharide‐activated microglia publication-title: Int. Immunopharmacol. – volume: 555 start-page: 33 year: 2004 end-page: 51 article-title: Targeting signal transduction pathways by chemopreventive agents publication-title: Mutat. Res. – volume: 286 start-page: C931 year: 2004 end-page: C939 article-title: CYP450 dietary inhibitors attenuate TNF‐alpha‐stimulated endothelial molecule expression and leukocyte adhesion publication-title: Am. J. Physiol. Cell Physiol. – volume: 481 start-page: 281 year: 2003 end-page: 291 article-title: The cyclo‐oxygenase‐2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats publication-title: Eur. J. Pharmacol. – volume: 42 start-page: 103 year: 2001 end-page: 110 article-title: Effects of tumor necrosis factor‐ synthesis inhibitors on rat trinitrobenzene sulphonic acid‐induced chronic colitis publication-title: Eur. J. Pharmacol. – volume: 425 start-page: 191 year: 2003 end-page: 196 article-title: Small molecule activators of sirtuins extend lifespan publication-title: Nature – volume: 27 start-page: 1265 year: 1998 end-page: 1274 article-title: Effect of antioxidants, resveratrol, quercetin, and ‐acetykcysteine, on the functions of cultural rat hepatic stellate cells and Kupffer cells publication-title: Hepatology – volume: 9 start-page: 408 year: 2003 end-page: 411 article-title: Resveratrol induces apoptosis in human esophageal carcinoma cells publication-title: World J. Gastroenterol. – volume: 279 start-page: G238 year: 2000 end-page: G244 article-title: Cyclooxygenase‐2‐derived prostaglandin D(2) is an early anti‐inflammatory signal in experimental colitis publication-title: Am. J. Physiol. Gastrointest. Liver Physiol. – volume: 59 start-page: 865 year: 2000 end-page: 870 article-title: Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production publication-title: Biochem. Pharmacol. – volume: 523–524 start-page: 145 year: 2003 end-page: 150 article-title: Molecular mechanism of the chemopreventive effect of resveratrol publication-title: Mutat. Res. – volume: 69 start-page: 7101 year: 2004 end-page: 7107 article-title: Antioxidant activity of hydroxystilbene derivatives in homogeneous solution publication-title: J. Org. Chem. – volume: 96 start-page: 795 year: 1989 end-page: 803 article-title: Hapten‐induced model of chronic inflammation and ulceration in the rat colon publication-title: Gastroenterology – volume: 49 start-page: 405 year: 2005 end-page: 430 article-title: Resveratrol as an anti‐inflammatory and anti‐aging agent: mechanisms and clinical implications publication-title: Mol. Nutr. Food Res. – volume: 19 start-page: 451 year: 2004 end-page: 460 article-title: Expression of apoptosis‐related proteins in rat with induced colitis publication-title: Int. J. Colorect. Dis. – volume: 96 start-page: 1290 year: 1989 end-page: 1300 article-title: Treatment with 16,16′‐dimethyl prostaglandin E before and after induction of colitis with trinitrobenzenesulfonic acid in rats decreases inflammation publication-title: Gastroenterology – volume: 33 start-page: 226 year: 2003 end-page: 231 article-title: Effects of resveratrol on lymphocyte proliferation and cytokine release publication-title: Ann. Clin. Lab. Sci. – volume: 102 start-page: 987 year: 2003 end-page: 995 article-title: Resveratrol blocks interleukin‐1{beta}‐induced activation of the nuclear transcription factor NF‐{kappa}B, inhibits proliferation, causes S‐phase arrest, and induces apoptosis of acute myeloid leukaemia cells publication-title: Blood – volume: 2 start-page: 1410 year: 2002 end-page: 1418 article-title: Role of peroxisome proliferator‐activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological diseases publication-title: Lancet – volume: 125 start-page: 1750 year: 2003 end-page: 1761 article-title: A murine model of chronic inflammation‐induced intestinal fibrosis down‐regulated by antisense NF‐kappa B publication-title: Gastroenterology – volume: 53 start-page: 329 year: 2004 end-page: 336 article-title: Blood flow alterations in TNBS‐induced colitis: role of endothelin receptors publication-title: Inflamm. Res. – volume: 47 start-page: 549 year: 2000 end-page: 555 article-title: Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes publication-title: Cardiovasc. Res. – volume: 98 start-page: 2372 year: 2003 end-page: 2382 article-title: Novel approaches to treating inflammatory bowel disease: targeting alpha‐4 integrin publication-title: Am. J. Gastroenterol. – volume: 25 start-page: 301 year: 2001 end-page: 309 article-title: Effects of a COX‐2 preferential agent nimesulide on TNBS‐induced acute inflammation in the gut publication-title: Inflammation – volume: 23 start-page: 2369 year: 2004 end-page: 2380 article-title: Modulation of NF‐kappaB‐dependent transcription and cell survival by the SIRT1 deacetylase publication-title: EMBO J. – volume: 186 start-page: 729 year: 1990 end-page: 742 article-title: Assessment of leukocyte involvement during ischemia and reperfusion of intestine publication-title: Methods Enzymol. – volume: 297 start-page: 915 year: 2001 end-page: 925 article-title: Colon epithelial cell death in 2,4,6‐trinitrobenzenesulfonic acid‐induced colitis is associated with increased inducible nitric‐oxide synthase expression and peroxynitrite production publication-title: J. Pharmacol. Exp. Ther. – volume: 28 start-page: 246 year: 2003 end-page: 249 article-title: Effects of tanguticum maxim polysaccharide on ulcerative colitis induced by TNBS in rats publication-title: Zhongguo Zhong Yao Za Zhi – volume: 236 start-page: 37 issue: (Suppl) year: 2002 end-page: 41 article-title: Blockade of NF‐kappaB activation and donation of nitric oxide: new treatment options in inflammatory bowel disease publication-title: Scand. J. Gastroenterol. – volume: 70 start-page: 305 year: 2004 end-page: 309 article-title: Resveratrol inhibits the release of mediators from bone marrow‐derived mouse mast cells publication-title: Planta Med. – volume: 275 start-page: 32681 year: 2000 end-page: 32687 article-title: Oxidized low density lipoprotein inhibits interleukin‐12 production in lipopolysaccharide‐activated mouse macrophages direct interactions between peroxisome proliferator‐activated receptor‐ and nuclear factor‐ B publication-title: J. Biol. Chem. – volume: 67 start-page: 1399 year: 2004 end-page: 1410 article-title: Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats publication-title: Biochem. Pharmacol. – volume: 3 start-page: 77 year: 2003 end-page: 93 article-title: Resveratrol and cancer: chemoprevention, apoptosis, and chemo‐immunosensitizing activities publication-title: Curr. Med. Chem. Anti-Cancer Agents – volume: 115 start-page: 874 year: 1998 end-page: 882 article-title: Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice publication-title: Gastroenterology – ident: e_1_2_6_51_1 doi: 10.1016/j.intimp.2003.07.002 – ident: e_1_2_6_56_1 doi: 10.1136/gut.52.12.1714 – ident: e_1_2_6_23_1 doi: 10.1182/blood-2002-11-3550 – ident: e_1_2_6_10_1 doi: 10.1016/S0304-3835(03)00157-5 – ident: e_1_2_6_4_1 doi: 10.1016/S0016-5085(89)80016-2 – ident: e_1_2_6_43_1 doi: 10.1002/hep.510270512 – ident: e_1_2_6_13_1 doi: 10.1016/j.mrfmmm.2004.05.018 – ident: e_1_2_6_20_1 doi: 10.1016/S0027-5107(02)00330-5 – ident: e_1_2_6_3_1 doi: 10.1002/mnfr.200500022 – ident: e_1_2_6_24_1 doi: 10.1016/0016-5085(90)90280-E – volume: 25 start-page: 9 year: 2004 ident: e_1_2_6_36_1 article-title: Recent advances in biological therapy for inflammatory bowel disease publication-title: Trop. Gastroenterol. contributor: fullname: KURTOVIC J. – ident: e_1_2_6_47_1 doi: 10.1021/np0498410 – ident: e_1_2_6_32_1 doi: 10.1038/nature01960 – ident: e_1_2_6_40_1 doi: 10.1016/j.bcp.2003.12.024 – volume: 33 start-page: 226 year: 2003 ident: e_1_2_6_14_1 article-title: Effects of resveratrol on lymphocyte proliferation and cytokine release publication-title: Ann. Clin. Lab. Sci. contributor: fullname: BOSCOLO P. – ident: e_1_2_6_15_1 doi: 10.2174/1568011033353443 – ident: e_1_2_6_34_1 doi: 10.1023/A:1012860509440 – ident: e_1_2_6_12_1 doi: 10.1016/S0014-2999(01)01410-8 – ident: e_1_2_6_50_1 doi: 10.1023/A:1026651408998 – volume: 297 start-page: 915 year: 2001 ident: e_1_2_6_55_1 article-title: Colon epithelial cell death in 2,4,6‐trinitrobenzenesulfonic acid‐induced colitis is associated with increased inducible nitric‐oxide synthase expression and peroxynitrite production publication-title: J. Pharmacol. Exp. Ther. contributor: fullname: YUE G. – ident: e_1_2_6_25_1 doi: 10.1016/S0006-2952(01)00775-4 – volume: 28 start-page: 246 year: 2003 ident: e_1_2_6_38_1 article-title: Effects of tanguticum maxim polysaccharide on ulcerative colitis induced by TNBS in rats publication-title: Zhongguo Zhong Yao Za Zhi contributor: fullname: LIU L. – ident: e_1_2_6_17_1 doi: 10.1007/s00384-004-0585-5 – ident: e_1_2_6_27_1 doi: 10.1016/0076-6879(90)86172-R – volume: 60 start-page: 3477 year: 2000 ident: e_1_2_6_31_1 article-title: Chemopreventive properties of trans‐resveratrol are associated with inhibition of activation of the IkappaB kinase publication-title: Cancer Res. contributor: fullname: HOLMES‐MCNARY M. – ident: e_1_2_6_16_1 doi: 10.1074/jbc.M002577200 – ident: e_1_2_6_21_1 doi: 10.1016/S0140-6736(02)11395-X – ident: e_1_2_6_53_1 doi: 10.1007/BF01954148 – ident: e_1_2_6_30_1 doi: 10.1042/bj3180603 – ident: e_1_2_6_41_1 doi: 10.1016/S0006-2952(99)00380-9 – ident: e_1_2_6_42_1 doi: 10.1016/S0016-5085(89)80079-4 – ident: e_1_2_6_39_1 doi: 10.1016/j.ejphar.2003.09.033 – ident: e_1_2_6_19_1 doi: 10.1080/003655202320621436 – ident: e_1_2_6_57_1 doi: 10.3748/wjg.v9.i3.408 – ident: e_1_2_6_18_1 doi: 10.1007/s00011-004-1266-0 – ident: e_1_2_6_7_1 doi: 10.1055/s-2004-818940 – volume: 51 start-page: 127 year: 2005 ident: e_1_2_6_46_1 article-title: Etiology and pathogenesis of inflammatory bowel disease publication-title: Minerva Gastroenterol. Dietol. contributor: fullname: SCHMIDT C. – ident: e_1_2_6_29_1 doi: 10.1207/S15327914NC4402_12 – ident: e_1_2_6_8_1 doi: 10.1016/S0006-2952(97)00544-3 – ident: e_1_2_6_44_1 doi: 10.1111/j.1572-0241.2003.08703.x – ident: e_1_2_6_48_1 doi: 10.1016/S0016-5085(98)70259-8 – ident: e_1_2_6_37_1 doi: 10.1053/j.gastro.2003.08.027 – ident: e_1_2_6_9_1 doi: 10.1016/S0014-2999(02)01494-2 – ident: e_1_2_6_54_1 doi: 10.1038/sj.emboj.7600244 – ident: e_1_2_6_2_1 doi: 10.1152/ajpgi.2000.279.1.G238 – ident: e_1_2_6_5_1 doi: 10.1021/jo0497860 – ident: e_1_2_6_6_1 doi: 10.1096/fj.04-3582fje – ident: e_1_2_6_45_1 doi: 10.1152/ajpcell.00351.2003 – ident: e_1_2_6_52_1 doi: 10.1016/S0014-2999(02)02949-7 – ident: e_1_2_6_26_1 doi: 10.1038/9550 – ident: e_1_2_6_49_1 doi: 10.1016/j.clnu.2005.02.009 – ident: e_1_2_6_11_1 doi: 10.1016/j.intimp.2004.08.008 – ident: e_1_2_6_35_1 doi: 10.1097/00054725-200409000-00010 – ident: e_1_2_6_33_1 doi: 10.1016/S0008-6363(00)00102-4 – ident: e_1_2_6_28_1 doi: 10.1038/sj.bjp.0705688 – ident: e_1_2_6_22_1 doi: 10.1097/00042737-200207000-00008 |
SSID | ssj0014775 |
Score | 2.3634386 |
Snippet | Neutrophil infiltration, proinflammatory cytokines, eicosanoid generation and oxidative stress have been implicated in colitis. Resveratrol is a polyphenolic... |
SourceID | pubmedcentral proquest crossref pubmed pascalfrancis wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 873 |
SubjectTerms | Animals Anti-Inflammatory Agents, Non-Steroidal - therapeutic use apoptosis Biological and medical sciences Colitis - chemically induced Colitis - drug therapy Colitis - metabolism Colitis - pathology Colon - drug effects Colon - metabolism Colon - pathology cyclooxygenase (COX) Cyclooxygenase 1 - metabolism Cyclooxygenase 2 - metabolism Dinoprostone - metabolism Gene Expression Regulation Inflammation - drug therapy Male Medical sciences Membrane Proteins - metabolism neutrophils NF-kappa B - metabolism nuclear transcription factor NF‐kappa B (NF‐κB) Peroxidase - metabolism Pharmacology. Drug treatments prostaglandin (PG) Prostaglandin D2 - metabolism Rats Rats, Wistar Resveratrol Sesquiterpenes Stilbenes - chemistry Stilbenes - therapeutic use Terpenes - chemistry Terpenes - therapeutic use Trinitrobenzenesulfonic Acid - toxicity trinitrobenzenesulphonic acid (TNBS) Tumor Necrosis Factor-alpha - metabolism Wine - analysis |
SummonAdditionalLinks | – databaseName: Wiley-Blackwell dbid: 33P link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BT0iINzQUqjmgcklK4zi2OfJo1RNaiSJxi-zYFqyqZNW0Rfsf-NGM7Wy2EUgIcYoij6XE_saesWe-AXjFXel1xWRRc6sKLrwrDLd1wZSVjvlQ2CoWsf0sP31VH48DTc6UxZ_4IaYDt6AZcb0OCq7NMKaJh8D1YXlolqtDgqwgF48WYXIVYg5HtZiuEbiUqYRBYEIsldqwNlbqzbz7bFe6u9IDDZBPlS3-ZHr-HkF507KNW9PJ_f__qQdwbzRL8V3C0UO45bpHcLBIvNbrHM-2aVpDjge42DJerx_DT2rGMTIEe4_kwl8HsuaL_jxHjTSTl70OzJsdWkL8tbMY0lpIzuKPEHefY99hm3h6kTBPME0plfRiCXyWnqg7vFmP4Hw9NbYxiG_AWNbnCXw5OT77cFqMZR6KtiZ_pjCSC-6VMZVjzBnrW1VLJ8h4sNZY4-uQLqsMM5x5LWmBkcK-LcMhqK2lKdvqKex0fed2AY80madW6ZBty1stNBdtKaRoNdk1vjrK4PVmmptVYvNo4i18pZph2dDQN-PQZ7A_Q8FWXEoyuco6g70NLJpR7YeG_LsyUDqpDJ4lgGz7CS45ZywDOYPOJBB4vuct3fdvke-7lCKQMmWQR-j85cub94tTRnbn838T34M76XQpBCW9gJ3Liyv3Em4P9mo_6tQvbsIo-A priority: 102 providerName: Wiley-Blackwell |
Title | The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1038%2Fsj.bjp.0706469 https://www.ncbi.nlm.nih.gov/pubmed/16474422 https://www.proquest.com/docview/217197808 https://pubmed.ncbi.nlm.nih.gov/PMC1760707 |
Volume | 147 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB66ORVK6btO2kWHkl7s3ViWJfXY5kFKaTE0hd6MnjTLxl7iJGX_Q390R7KdzdJCoRcbIwkbzyfrG3nmG4A3zOVeFVRkJbMyY9y7TDNbZlRa4agPha1iEduv4st3eXQcZHLKMRcmBu0bfT5rlhez5vxHjK1cXZj5GCc2rz4f5oIHlZr5BCbIDUcXffh1wIToyxYE9cNcylGpsZDzbjHTi9UMx3L0CoNeKGeCMUq3FqUHK9Xh-_F9YYu_Mc8_AyjvEtu4Mp08gocDpSTv-0d_DPdc8wT2q16Tep2Ss02KVZeSfVJt1KrXT-EXNpMhqoO0nqD7fROEli_bZUoUQStctSqoZjbEIlpvnCUhJQX7WfIzxMynpG2I6TV2CeIVIdanQ-KFReBYPBPVkLu1BJbr20YTA_A6EkvyPINvJ8dnh6fZUKIhMyX6IpkWjDMvtS4cpU5bb2QpHMeF31pttS9DqqvUVDPqlcCPg-D2XR42MG0pdG6K57DTtI17CeRAIbW0UoVMWWYUV4ybnAtuFHISXxwk8Ha0Ub3qlTjq-Ae9kHW3qNGw9WDYBKZbJtx0FwLpUl4msDfatB6mbFejb5YHOSaZwIveuptxA0wSEFt2v-0QNLq3WxC6Uat7gGoCaUTIP568_lCdUuSMu_99oz24328ShdiiV7BzdXntXsOks9dTmBRFhcejj5-mccr8BoHnG6Y |
link.rule.ids | 230,315,729,782,786,887,1408,27933,27934,46064,46488,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwEB3RcgCp4psSCmUOqFw2pXEc2xwLtFpEqVZikbhFdmwLVlWyatqi_Q_8aMZxdrcRSAiJUxR5LCX2G3s8nnkD8JK7zOucybTgVqVceJcabouUKSsd86GwVVfE9rM8_areHwWanMNlLkzkh1g53IJmdOt1UPDgkO7zxEPkejvbN7P5PmFW0BlvA25yQWgMWRz5ZHWRwKWMRQwCF2Km1JK3MVevh_0H-9LWXLc0RD7WtviT8fl7DOV127bbnI7v_offugd3essUDyOU7sMNVz-AvUmktl6McLrO1GpHuIeTNen14iH8pGbsg0Ow8Uin-KvA13zenI1QI03mRaMD-WaNlkB_5SyGzBaSs_gjhN6PsKmxilS9SLAnpMasSnqxhD9LT9Q1Xi9JcLZYNVZdHF-LXWWfR_Dl-Gj6bpz2lR7SqqAjTWokzZ1XxuSOMWesr1QhnSD7wVpjjS9CxqwyzHDmtaQ1Rgr7Jgt-UFtIk1X5Y9ism9o9ATzQZKFapUPCLa-00FxUmZCi0mTa-PwggVfLeS7nkdCj7C7ic1W2s5KGvuyHPoHdAQzW4lKS1ZUVCewscVH2mt-WdMTLAquTSmA7ImTdT3DJOWMJyAF2VgKB6nvYUn__1lF-Z1IEXqYERh12_vLl5dvJmJHp-fTfxF_ArfH000l58uH04w7cjs6mEKP0DDYvzi_dc9ho7eVup2C_AAHpLSA |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fa9UwFD64CSIMfzvrdOZB5ks71zRN4qO6XSbKKDjBt5I0CXoZ7WXdJvd_8I_2JOntXVEQ8amUnECbfEm-JOd8B-Als7lTBRVZyYzMGHc208yUGZVGWOp8YquQxPazOPkqD4-8TM4YxR_1IcYDNz8ywnztB_jCuCFM3Duu9_N9PV_sI2Q5bvE24CZDLu7V84uiGu8RmBAxh4GXQsylXMk2FvL1tP5kWdpaqB5byMXUFn_inr-7UF6ntmFtmt39_7-6B3cGXkreRiDdhxu2fQB7VRS2XqbkdB2n1adkj1RryevlQ_iJxWRwDSGdI7iHv_JqzefdWUoUwa686JSX3myJQchfWUN8XAvaGfLDO96npGtJE4V6CYIecRpjKvHFIPoMPolqyfWEBGfLsbAJXnw9CXl9HsGX2dHp--NsyPOQNSVuaDItGGdOal1YSq02rpGlsBzZgzHaaFf6eFmpqWbUKYEzjODmTe5PQU0pdN4Uj2Gz7Vr7BMiBQn5qpPLhtqxRXDHe5FzwRiGxccVBAq9W3VwvopxHHa7hC1n38xqbvh6aPoHdCQrW5kIg58rLBHZWsKiHcd_XuMHLvaaTTGA7AmRdjzPBGKUJiAl0RgMv9D0tab9_C4LfueBelSmBNEDnL19ev6uOKRLPp_9m_gJuVYez-tOHk487cDueNHkHpWeweXF-aZ_DRm8ud8Pw-gVFlSvG |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effects+of+resveratrol%2C+a+phytoalexin+derived+from+red+wines%2C+on+chronic+inflammation+induced+in+an+experimentally+induced+colitis+model&rft.jtitle=British+journal+of+pharmacology&rft.au=Mart%C3%ADn%2C+Antonio+Ram%C3%B3n&rft.au=Villegas%2C+Isabel&rft.au=S%C3%A1nchez%E2%80%90Hidalgo%2C+Marina&rft.au=De+La+Lastra%2C+Catalina+Alarc%C3%B3n&rft.date=2006-04-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0007-1188&rft.eissn=1476-5381&rft.volume=147&rft.issue=8&rft.spage=873&rft.epage=885&rft_id=info:doi/10.1038%2Fsj.bjp.0706469&rft.externalDBID=10.1038%252Fsj.bjp.0706469&rft.externalDocID=BPH2639 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1188&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1188&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1188&client=summon |